This review will discuss therapeutic effects of the most influential chemokines with a special ... and adaptive immunity [81] pDNA (gB) + pDNA (CXCL10) PrV challenge More resistant to a virulent ...

Coadministration of chemokine with antigen: coadministration of pDNA or recombinant protein encoding chemokines with antigen ... immunity [81] pDNA (gB) + pDNA (CXCL10) PrV challenge More ...

Inhibition of cellular recycling mechanism—autophagy—by targeting selectively a key protein VPS34 leads to an increase in specific chemokines, CCL5 and CXCL10, which act like beacons ...

announced a successful private placement led by Velan Capital, raising approximately $15 million to advance its CXCL10 antibody ... therapeutics for immuno-inflammatory diseases, today announced ...